Methemoglobinemia screening: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 5: Line 5:
==Overview==
==Overview==


'''Congenital (Hereditary) Methemoglobinemia'''
[[Methemoglobinemia]] screening is not routinely done.
 
There are three main congenital conditions that lead to methemoglobinemia:
 
1. [[Cytochrome b5 reductase deficiency]] and [[pyruvate kinase deficiency]]
 
2. [[G6PD deficiency]]
 
3. Presence of abnormal hemoglobin ([[Hb M]])
 
 
'''Acquired or Acute Methemoglobinemia'''
 
Some of the most common causes include different [[oxidant drugs]], [[toxins]] and [[chemicals]].


==Screening==
==Screening==

Revision as of 13:57, 15 May 2018

Methemoglobinemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Methemoglobinemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Methemoglobinemia screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Methemoglobinemia screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Methemoglobinemia screening

on Methemoglobinemia screening

Methemoglobinemia screening in the news

Blogs on Methemoglobinemia screening

Directions to Hospitals Treating Methemoglobinemia

Risk calculators and risk factors for Methemoglobinemia screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Template:Aksiniya K. Stevasarova, M.D.

Overview

Methemoglobinemia screening is not routinely done.

Screening

Currently in the United States the newborn screening for G6PD is not routinely done. It is performed only in neonates presenting with jaundice. [1]

Currently we have a screening test for G6PD deficiency that has been tested in Thai population, since G6PD is very common in this pateint population. It is called methemoglobin reduction test (MRT), it is not expensive and it uses cord blood of neonates to check for the enzyme deficiency. Even though it has low sensitivity around 65%, it does have acceptable specificity arounf 90%. [2]

Referrences

  1. "PMID: 10916676" Baillieres Best Pract Res Clin Haematol. 2000 Mar;13(1):21-38. Glucose-6-phosphate dehydrogenase deficiency. Mehta A1, Mason PJ, Vulliamy TJ.
  2. "pmid11529386" J Med Assoc Thai. 2001 Jun;84 Suppl 1:S91-8. The value of methemoglobin reduction test as a screening test for neonatal glucose 6-phosphate dehydrogenase deficiency. Sanpavat S1, Nuchprayoon I, Kittikalayawong A, Ungbumnet W.

Template:WS Template:WH